Introduction
Thyroid hormones exert a range of developmental and physiological actions in all vertebrates. Serum concentrations of -thyroxine (T4) and 3,5,3 --tri-iodothyronine (T3) are maintained by a negative feedback loop involving T3 inhibition of hypothalamic thyrotrophin-releasing hormone (TRH) and pituitary thyroid-stimulating hormone (TSH) secretion, and by tissue-specific and hormoneregulated expression of the three iodothyronine deiodinase enzymes that activate or metabolise thyroid hormones (Bianco et al. 2002) . T3 actions are mediated by two T3 receptors, TR and TR , which act as hormoneinducible transcription factors. The TR (NR1A1) and TR (NR1A2) genes encode mRNAs that are alternatively spliced to generate nine mRNA isoforms (TR 1, 2, 3, 1, 2, 1, 2, 3 and 3), of which four (TR 1, 2, 1 and 2) are known to be expressed at the protein level in vivo (Lazar 1993 , Chassande et al. 1997 , Williams 2000 (Fig. 1) . The numerous TR mRNAs are expressed widely in tissue-and developmental stagespecific patterns, although it is important to note that levels of mRNA expression may not correlate with receptor protein concentrations in individual tissues (Forrest et al. 1990 , Schwartz et al. 1994 . The TR 2, 3, 1 and 2 transcripts encode proteins that fail to bind T3 in vitro. These 'non-binding' isoforms, in addition to TR 3 which does bind hormone, may act as dominant negative antagonists of the true T3-binding receptors in vitro, but their physiological functions and those of the TR 3 isoform have not been determined. In order to obtain a new understanding of the complexities of T3 action in vivo and the role of TRs during development, many mouse models of disrupted or augmented thyroid hormone signalling have been generated. The aim of this review is to provide a picture of the physiological actions of thyroid hormones by considering the phenotypes of these genetically modified mice.
Endocrine system
TR 0/0 knockout TR 0/0 mice lack expression of all products of the TR locus (Table 1) . Animals survive normally and are fertile with normal basal thyroid status and pituitary growth hormone (GH) mRNA concentrations . Nevertheless, compared with wild-type littermates, TR 0/0 mice display increased sensitivity to thyroid hormones in the pituitary and liver following provocative testing with increasing doses of T3 to suppress TSH and T4 secretion (Macchia et al. 2001) .
TR / knockout
Disruption of exon 2, the first coding exon within the TR locus, prevents transcription of both TR 1 and TR 2 mRNAs, but does not interfere with expression of TR 1 and 2 from an internal promoter in intron 7 (Chassande et al. 1997 , Fraichard et al. 1997 (Table 1) . TR / pups die shortly after weaning unless treated with T3 (Fraichard et al. 1997) . The thyroid gland develops abnormally and homozygous mutants are profoundly hypothyroid with T3 and T4 concentrations reduced to 40% and <10% of wild-type concentrations by 5 weeks of age. The greater reduction in T4 compared with T3 suggests that progressive hypothyroidism results from defective hormone production rather than an abnormality in peripheral T3 production (Fraichard et al. 1997) . Accordingly, pituitary TSH mRNA expression was decreased more than 3-fold in TR / animals although GH mRNA levels were unaffected. Homozygous mutants die within 5 weeks, although they can be rescued by hormone replacement for only 1 week (1 µg T3 subcutaneous injection) during the third week of life at the time of weaning. Thereafter, animals gain weight and hormone levels of 2·5-month-old rescued animals are normal (Fraichard et al. 1997) , although both male and female TR / mice are infertile. These data indicate a stimulatory role for TR 1 or 2 in the initiation of thyroid hormone production at weaning or a suppressive role for the truncated 1 and 2 products that continue to be expressed in TR / mice.
Figure 1
Thyroid hormone receptor isoforms. Protein products arising from the TR and TR genes are displayed below a schematic diagram of the functional domains present within proteins of the nuclear receptor superfamily. Numbering represents the amino acid positions within the rat TR proteins. Shading indicates identical shared regions and differences between TR variants that are translated from alternately spliced mRNA isoforms. Salto et al. (2001) 2, 2 1 (over-espressed), 1, all isoforms
Mixed hyper/ hypothyroid TR 0/0 Gauthier et al. (2001) All isoforms All isoforms Euthyroid TR / Forrest et al. (1996b) A l l isoforms All isoforms RTH TR 2 / Abel et al. (1999a) , Ng et al. (2001) mice was normal. Reduced T4 levels in males occurred in association with a small reduction in TSH concentrations and reduced pituitary TSH , but not TSH , mRNA expression. These data suggest that the mild hypothyroidism in male TR 1 / mice results from impaired TSH gene regulation (Wikstrom et al. 1998) . In combination with findings in TR / mice (Forrest et al. 1996a,b) , these studies suggest a model in which TSH gene expression is dynamically regulated by interactions between individual isoforms expressed by both TR and genes (Wikstrom et al. 1998) . . Free T3 and T4 concentrations are reduced, but TSH concentrations are inappropriately normal and there is impaired hormone production from the thyroid gland. Nevertheless, there are also features of hyperthyroidism such as increased heart rate, weight loss and elevated body temperature, suggesting that tissue-specific differences in thyroid hormone responsiveness may depend on the amount of TR 1 expressed. Thus, the TR 1: 2 ratio may regulate hormone responsiveness in specific tissues. Female TR 2 / mice have a prolonged oestrous cycle due to abnormal patterns of ovulation that are reflected by impaired fertility. In contrast, the TR 2 / mice have normal GH levels but there is a decrease in circulating insulin-like growth factor-I (IGF-I) concentrations, suggesting that GH signalling requires tissue euthyroidism.
TR
/ knockout TR / mice, which lack expression of all TR isoforms (Table 1) , display resistance to thyroid hormone (RTH) and demonstrate the key role for TR in set-point control of the pituitary-thyroid feedback axis (Forrest et al. 1996b . There is enlargement of the thyroid gland with an increased size and number of follicles. The inappropriate elevation of TSH is accompanied by selective 2·5-and 3·3-fold rises in pituitary TSH and TSH mRNA expression, suggesting that RTH results from defective thyrotroph function rather than hyperplasia or pituitary gland malformation (Forrest et al. 1996b) . Following the suggestion that TR may regulate TSH gene transcription directly (Forrest et al. 1996b ), further studies (Weiss et al. 1997 ) revealed that TR is not required for increased TSH expression in hypothyroidism and is not essential for T3-mediated repression of TSH. Thus, TR enhances the sensitivity of the system and is necessary for complete inhibition of TSH, thereby resulting in the RTH phenotype in TR / mice (Weiss et al. 1997) . These data are in accord with previous studies in vitro, which indicate that TRH is negatively regulated by T3 acting via TR (Lezoualc'h et al. 1992) and suggest that TR -mediated control of the pituitary-thyroid axis operates at the level of the hypothalamus as well as the pituitary. Although TR / mice display features of RTH similar to those observed in humans, they provide a recessive model for this condition whereas RTH in man is autosomal dominant (Forrest et al. 1996a,b) . TR / mice also exhibit impaired T3-dependent regulation of cholesterol metabolism (Gullberg et al. 2000 , Macchia et al. 2001 , supporting previous observations showing that basal cholesterol levels were elevated in TR / mice, despite elevated basal T4 concentrations (Weiss et al. 1998) , thus demonstrating peripheral as well as pituitary RTH.
TR 2 / knockout
To elucidate further the role of TR in pituitary-thyroid feedback control, TR 2 / mice were generated (Abel et al. 1999a) (Table 1) . These mice also have RTH with a 3-fold increase in basal T4 concentrations, a 40% increase in T3, a 2·5-fold elevation in TSH and defective TSH suppression following T3 administration. Pituitary TSH mRNA was increased in TR 2 / mice and there was impaired stimulation of pituitary GH mRNA following T3 administration, adding to previous evidence indicating that TR 2 plays a major role in T3-stimulated GH mRNA expression (Ball et al. 1997) . Thus, deletion of TR 2 is sufficient to cause RTH, suggesting that TR 1 cannot adequately substitute for 2 and that 2 primarily mediates feedback control. This hypothesis is supported by studies which indicate that TR 2 is a more potent regulator of TSH mRNA than 1 (Ng et al. 1995 , Safer et al. 1997 ). More recently, Ng et al. (2001) developed Thrb tm2Df/tm2Df mutant mice, which also lack expression of TR 2. These mice display milder RTH than observed by the same group previously in TR / mice (Forrest et al. 1996b ) and milder than observed in TR 2 / mice reported by Abel et al. (1999a) . Thus, Ng et al. (2001) concluded that 2 acts co-operatively with 1 to regulate the pituitary-thyroid axis, in contrast to conclusions from the studies discussed above that suggest that 2 is the primarily important isoform (Abel et al. 1999a) . Although the two laboratories each report mice that lack TR 2, their phenotypic differences may result from the differing gene targeting strategies employed by the two groups or from differences in genetic background of the mice. Thus, it is difficult to conclude at this stage precisely how much contribution to control of the pituitary-thyroid axis is made by TR 2 relative to 1 in vivo or whether other modifier genes are influential.
TR 0/0 / double knockout
Deletion of all TR isoforms in TR 0/0 / mice ) results in profound abnormalities of the pituitary-thyroid axis with concentrations of T4, T3 and TSH elevated 14-fold, 13-fold and more than 200-fold respectively, which are similar to findings in TR 1 / / (Gothe et al. 1999) and TR / / mice . Pituitary GH mRNA expression is markedly reduced in TR 0/0 / double mutant mice in contrast to TR 0/0 animals, in which expression is preserved , providing further evidence that T3 regulation of GH occurs via TR .
The high levels of TSH in TR 0/0 / mice are around half those reported in Pax8 / mice (Flamant et al. 2002) in which the primary defect is an absence of thyroid follicular cells (Mansouri et al. 1998) (Table 1 ). The number of pituitary thyrotrophs is markedly elevated in both Pax8 / and TR 0/0 / mice and TSH gene expression is similar in both genotypes (Flamant et al. 2002) . These similar features occur despite the fact that Pax8 / mice have no circulating T3 and T4 whilst TR 0/0 / mice have markedly elevated peripheral hormone concentrations and suggest that programming of the numbers of developing pituitary thyrotrophs occurs independent of thyroid hormones or TRs.
We have selected Pax8 / mice (Mansouri et al. 1998) as the best available genetic model of isolated thyroid hormone deficiency for comparison with mice harbouring TR deletions. Whilst it remains possible that Pax8 has additional and uncharacterised functions in tissues other than the thyroid gland, the phenotype of Pax8 / mice appears to result solely from hypothyroidism. Furthermore, Pax8 / mice have been crossed with various TR-deficient mice (Flamant et al. 2002) enabling objective phenotypic comparisons to be made with TR-null mice. Nevertheless, alternative genetic models of hypothyroidism including the Ames (df/df ) and Snell (dw/dw) dwarf and hyt/hyt (Beamer et al. 1981) hypothyroid mutants have been reported. Whilst these mice provide further useful tools for the further understanding of T3 action, the df/df and dw/dw mutants develop hypothyroidism secondary to hypopituitarism resulting from mutations of the prophet of Pit-1 (Sornson et al. 1996) and Pit-1 ) transcription factors respectively, whilst congenital hypothyroidism in hyt/hyt mice results from a mutation of the TSH receptor (Stein et al. 1994) (Flamant et al. 2002) and support similar conclusions derived from TR / mice (Fraichard et al. 1997) .
TR / / double knockout
In TR / / mice, T4 and T3 levels were elevated 10-fold and TSH increased more than 100-fold . There was concomitant thyroid gland enlargement with follicular cell hyperplasia, an increase in the number of follicles, which were smaller than seen in TR / mice, and evidence of abnormal colloid production and increased vascularity of the gland . As in the case of TR / animals (Fraichard et al. 1997) , TR / / mice die following weaning , further implicating the TR 1 and 2 isoforms in the generation of this phenotype.
TR 1
/ / double knockout Gothe et al. (1999) reported the phenotype of TR 1 / / mice. Free T3 and T4 concentrations were elevated 60-fold with a 160-fold increase in TSH in 4-to 8-week-old mice that reduced to a 60-fold elevation at 5 months of age. There was a 15-fold increase in thyroid gland weight with hyperplasia and proliferation of follicular cells leading to progressive goitre. TSH and TSH mRNA levels were increased 3·3-and 26-fold respectively in double mutant pituitary glands, although the pituitary gland was not malformed or enlarged. Similar to Pax8 / and TR 0/0 / mice (Flamant et al. 2002) , there were increased numbers of pituitary thyrotrophs reflecting the enhanced TSH secretion in TR 1 / / mice (Gothe et al. 1999) . The growth-promoting actions of GH have been shown to occur, in part, via IGF-I (Ohlsson et al. 1998) . IGF-I and GH levels were reduced in TR 1 / / mice and may be a cause of retarded growth (Gothe et al. 1999 
Transgenic models of human RTH
RTH has been classified as generalised (GRTH) or pituitary (PRTH) according to the absence or presence of thyrotoxicosis. Hayashi et al. (1998) selected the natural TR mutant G345R which causes severe RTH in man (Sakurai et al. 1989) , and produced a transgenic mouse with the mutant TR targeted to the pituitary, under the control of the TSH promoter (Table 2) . Pituitary-specific expression of TR G345R resulted in PRTH with increased serum T4 and reduced cholesterol levels but normal TSH concentrations. These findings reflected thyrotroph resistance to T3 and normal hepatic responsiveness, although the phenotype was milder than predicted from the human disease. TR G345R transgenic mice were normal in terms of fertility, survival and growth (Hayashi et al. 1998) .
The naturally occurring mutation 337T (Usala et al. 1991 , Baniahmad et al. 1992 was introduced into human TR 1 (Abel et al. 1999b) . The TR 337T mutant does not bind T3 and is associated with severe GRTH (Usala et al. 1991) . Abel et al. (1999b) generated TR 337T transgenic mice, selectively targeted to the pituitary via the common -subunit promoter (Table 2 ). There was a 3-fold increase in TSH but normal circulating T4 suggesting the possibility of reduced TSH bioactivity. Previous studies have indicated that TRH enhances the biological activity of TSH via alteration of TSH glycosylation (Beck-Peccoz et al. 1985 , Taylor et al. 1988 , Taylor & Weintraub 1989 . This concept was supported recently by Yamada et al. (1997) who demonstrated that mice with a targeted ablation of TRH have T4 levels 50% lower than wild-type mice despite 2-fold elevated TSH concentrations. RTH patients have been observed to have increased bioactive TSH (Persani et al. 1994) and, thus, differences in TRH production may explain differences between human RTH patients and pituitary-specific TR 337T transgenic mice (Abel et al. 1999b) . TR 337T animals also show impaired ligand-independent activation of TSH gene expression in vivo and deficient TSH responsiveness to hypothyroidism. The results indicate that the pituitary-specific expression of TR 337T leads to impaired T3-mediated repression, with defective T3-independent activation of TSH production, and that resistance at the level of both the pituitary and the hypothalamus is required for thyroid hormone elevation in RTH (Abel et al. 1999b) .
A third RTH mutant, TR PV , was introduced into transgenic mice under the control of the human -actin promoter to ensure ubiquitous expression (Table 2 ). Mice displayed features of RTH with elevated thyroid hormone levels and inappropriately normal TSH (Wong et al. 1997 ). Subsequently, Zhu et al. (1999) generated a transgenic mouse with the TR PV mutant targeted to the pituitary using the common -subunit promoter. Male TR PV mutant mice exhibited impaired weight gain but there were no alterations in T3, T4 or TSH compared with wild-type mice. Levels of GH and IGF-I were also unaffected, suggesting that impaired growth might be mediated by alternative factors (Zhu et al. 1999) .
A major problem with the transgenic approach is that the mutant TR is introduced and expressed under the control of a heterologous promoter that might be ubiquitous or tissue specific but does not possess the regulatory features of the endogenous TR promoter. Furthermore, random integration of the transgene into host DNA may result in altered expression of other unknown potential modifier genes; the mutant receptor is introduced in the presence of both normal alleles of the native receptor; and transgene copy number may be important. These features suggest that a transgenic approach is unlikely to produce a faithful mouse model of RTH in which to understand physiological activities of TR isoforms in specific tissues. Kaneshige et al. (2000) addressed these issues by targeting the TR PV mutation to the endogenous mouse TR gene by homologous recombination to generate a TR PV 'knock-in' mutant model of RTH (Table 3 ). The PV mutation was derived from a patient with severe RTH, who had elevated T4 and T3 levels, normal TSH, short stature, goitre and tachycardia (Parrilla et al. 1991) . The mutation in exon 10 is a C insertion at codon 448 which produces a frameshift of the carboxy-terminal 14 amino acids (aa) of TR , resulting in severe impairment of T3 binding and transactivation activity by the mutant TR PV protein, which acts as a dominant negative TR in vitro (Kaneshige et al. 2000) . Heterozygous TR PV/+ mice showed biochemical features of RTH that were typical of those in human RTH, whilst homozygous TR PV/PV mutants had severe RTH with disruption of the pituitary-thyroid feedback axis and impaired growth (Kaneshige et al. 2000) . T3 concentrations were elevated 2-and 9-fold in TR PV/+ and TR PV/PV mice respectively, and T4 levels were increased 2·5-and 15-fold in heterozygous and homozygous mutant mice. RTH was profound in TR PV/PV mice in which 412-fold increased TSH concentrations were seen. TR PV mice possessed thyroid glands of increased size with extensive hyperplasia seen in homozygous mutants. The PV mutation interfered with the activities of wild-type receptors on the expression of both -glycoprotein subunit and TSH genes and GH expression was repressed to 20% of wild-type values in TR PV/PV pituitaries. In heterozygous TR PV/+ mice, there was a reduced GH mRNA response to elevated T3 levels (Kaneshige et al. 2000) . Previous biochemical data have shown that TR PV mutant receptors form inactive heterodimers with wild-type TR or TR 1, with TR having a higher interaction affinity than TR 1 for TR PV (Zhu et al. 1996a) . However, several mechanisms can be proposed to account for the dominant negative effect of mutant TR PV . Thus, the mild pituitary-thyroid abnormalities in TR PV/+ mice might result from the formation of inactive or repressive TR PV -containing heterodimers, from indirect interference with the actions of one or both TR 1 and TR by TR PV , from haplo-insufficiency of wild-type TR or a combination of such factors (Kaneshige et al. 2000) . Kaneshige et al. (2001) investigated this by generating mice with the PV mutation in TR 1 (Table 3) . TR 1 PV/+ mice are dwarfs and have impaired fertility with reduced litter size and frequency of pregnancy. Although viable, mortality was high, a clear difference from the TR PV mice. TR 1 PV/PV homozygotes were especially rare after mating TR 1 PV/+ animals and when born they died in the early neonatal period. TR 1 PV/+ mice had normal T4, but elevated T3 and TSH levels with no histological abnormality of the thyroid gland. The elevated TSH, together with reduced T4:T3 ratio, suggests that mild thyroid failure occurs in TR 1 PV/+ mice. There was no effect observed on pituitary GH expression but a 2-to 3-fold increased common -subunit mRNA expression was observed. TSH mRNA was unaffected, suggesting that increased circulating TSH concentrations may result from increased TSH protein translation, secretion or stability. The distinct phenotypes seen in the TR 1 PV (Kaneshige et al. 2001 ) and TR PV (Kaneshige et al. 2000) mice demonstrate that functions of the TR mutants are isoform specific in vivo and show that, although no TR mutations have been documented in human RTH, dominant mutations affecting TR are neither silent nor lethal. Thus, it seems probable that mutations of TR are likely to exist in man, but that their resulting biochemical and general phenotypes would be predicted to be quite distinct from the RTH associated with TR mutations.
Models of RTH using targeted mutagenesis

Skeleton and growth
TR
0/0 homozygous mice are proportionately growth retarded with reduced weight gain and preservation of a normal weight-to-length ratio, whereas heterozygotes grow normally . Growth retardation results from delayed endochondral bone formation. There is a failure of progression of hypertrophic chondrocyte differentiation in the epiphyseal growth plate, which is disorganised and immature. Bone mineralisation is impaired and trabecular bone density in the tibial metaphysis is reduced compared with wild-type mice ( Gauthier et al. 2001) . These features are similar to those seen in hypothyroidism (Stevens et al. 2000) , although in the basal state TR 0/0 mice are biochemically euthyroid and have normal levels of pituitary GH , suggesting a defect in skeletal T3 responsiveness due to deletion of TR . TR / -null mice are growth retarded with markedly delayed endochondral ossification (Fraichard et al. 1997) , although these features are not manifest until the end of the second postnatal week. By the fifth postnatal week, TR / mice lose up to 50% body weight and die, failing to survive beyond weaning. Skeletal analyses revealed normal morphology with significantly delayed ossification and mineralisation and a hypoplastic bone marrow. Histomorphometry showed reduced bone mass and increased areas of disorganised epiphyseal cartilage containing reduced numbers of hypertrophic chondrocytes (Fraichard et al. 1997 heterozygotes showed evidence of impaired mineralisation in endochondral, but not intra-membranous bones, manifest by reduced bone mineral density and content . There was evidence of reduced tibial cortical bone in TR 2 / mice, suggesting late-onset growth retardation as these parameters may result from reduced periosteal bone growth in adults. A possible explanation for the adult onset growth retardation with reduced cortical bone in TR 2 / mice is that lack of TR 2 or over-expression of TR 1 results in late-onset IGF-I deficiency .
Complete deletion of TR or TR 2 results in PRTH as indicated above, but does not cause growth retardation and no skeletal abnormalities have been reported in TR / -or TR 2 / -null mice (Abel et al. 1999a .
Growth retardation in TR 0/0 / double mutant mice is more severe than that seen in TR 0/0 single mutant animals despite the observation that TR / mice grow normally . These data suggest that some important growth-promoting actions may be performed by TR in TR 0/0 mutant mice. Nevertheless, GH production is also diminished in TR / animals indicated that more severe growth retardation and further delay in endochondral ossification occurs in Pax8 / mice, suggesting that unliganded apo-TRs also exert deleterious effects during bone formation in the complete absence of thyroid hormones (Flamant et al. 2002) . TR / / mice exhibit a similar skeletal phenotype to TR / animals . There are no morphological alterations at birth whilst, similar to TR / mice (Fraichard et al. 1997) , double mutants undergo growth arrest and die at 5 weeks of age. Examination of the skeleton demonstrated delayed endochondral ossification with reduced mineralisation at 2 weeks of age, findings similar to those in TR / mice . At this age, thyroid hormone concentrations in TR / / mice did not differ from wild-type mice, indicating that skeletal abnormalities did not result from circulating hypothyroidism but were due to the TR / / deletion . TR 1 / / mice (Gothe et al. 1999 ) are growth retarded from 3 weeks of age and by adulthood weigh 30% less than wild-type mice, with a disproportionate reduction in long bone length, delayed ossification and disorganisation of the growth plate. The bone defects resemble hypothyroidism, although in hypothyroidism the width of the tibial growth plate is reduced (Lewinson et al. 1989) , whereas in TR 1 / / mice it is the reverse (Gothe et al. 1999) . The skeletal abnormalities in TR 1 / / mice are associated with inhibition of the GH-IGF-I axis. Interestingly, growth retardation in TR 1 / / mice is reversed following GH replacement, but the growth plate ossification abnormalities are not rescued , indicating that TRs provide important actions to regulate the activity of the GH-IGF-I axis and also exert direct effects on the skeleton.
Transgenic TR PV mutant mice exhibited impaired weight gain compared with wild-type mice that was sexually dimorphic. Impairment of weight gain was evident in males expressing the transgene in all tissues (Wong et al. 1997) or in the pituitary gland only (Zhu et al. 1999) . In females, growth retardation was less prominent and did not occur in animals with restricted expression of TR PV in the pituitary.
Reduced bone length and impaired weight gain was also seen in TR PV knock-in mice (Kaneshige et al. 2000) , in which significantly shortened tibiae and femora were documented in both TR PV/+ and TR PV/PV mice, with homozygotes more severely affected but no sexual dimorphism identified. Homozygous mutants also displayed a reduced growth spurt by up to 40% between 3 and 7 weeks of age. No differences were seen in TR Four-week-old male TR 1 PV/+ mice weighed 40% less and were 17% shorter than wild-type siblings, whilst females weighed 30% less than wild-type mice and were 15% shorter (Kaneshige et al. 2001) .
Skeletal muscle
Hypo-and hyperthyroidism in humans cause skeletal muscle weakness with fatigue and T3 plays an important role during skeletal muscle development (Gambke et al. 1983) by repressing or activating expression of MHC genes (Yu et al. 2000) . Johansson et al. (2000) found that alterations in thyroid hormone levels induce changes in maximum shortening velocity (V0) and in isometric twitch contraction or relaxation times. V0 depends mainly upon myosin composition of the contractile proteins, the slow type MHC I and the faster MHC II isoforms (Schiaffino et al. 1989 , Ennion et al. 1995 . Thyrotoxicosis induces a shift towards faster MHC isoforms (Caiozzo et al. 1993) and hypothyroidism reverses this equilibrium (Johansson et al. 2000) . Contraction and relaxation times also depend on the Ca 2+ transport capacity of the sarcoplasmic reticulum Ca 2+ -ATPase (SERCa), of which there are fast (SERCa1) and slow (SERCa2) types in skeletal muscle (Johansson et al. 2000) . Hypothyroidism causes a decrease in both SERCa1 and SERCa2 activity (Sayen et al. 1992) ; this trend is reversed in thyrotoxicosis (Muller et al. 1994) .
The actions of T3 in skeletal muscle have been studied in only a few of the TR mutant mice. TR 1 / mice exhibit a hypothyroid phenotype with longer muscle contraction and relaxation times and soleus muscle twitches extended by 40%. In TR / mice, the soleus muscle was less fatigue resistant than in wild-type mice although contraction and relaxation times were unchanged (Johansson et al. 2000 (Yu et al. 2000) and suggest that both TR 1 and TR are required for normal skeletal muscle responses to T3 (Johansson et al. 2000) .
Visual and auditory systems
Retinal cone photoreceptors facilitate colour vision (Ng et al. 2001) . Cones expressing different opsin photopigments are sensitive to short (S, 'blue') and middle (M, 'green') wavelengths in rodents, and these cones are differentially localised in the retina (Wang et al. 1992 , Szel et al. 2000 . Thyroid hormone has been implicated in the differentiation of cones (Kelley et al. 1995a,b) and mutations of TR may be associated with cone disorders in man (Newell & Diddie 1977) . TR 1 is widely expressed, whereas the expression of TR 2 is largely restricted to the hypothalamus, pituitary, inner ear (Hodin et al. 1989 , Bradley et al. 1994 ) and the outer nuclear layer of the embryonic retina that contains developing photoreceptors (Sjoberg et al. 1992) . The mouse retina contains S-and M-opsin specific cones as well as cones expressing both , Lyubarsky et al. 1999 . Deletion of TR 2 causes a selective loss of M-cones together with an increase in S-opsin immunoreactive cones. The cone distribution gradient is also disturbed with the usually focussed S-cones becoming widespread across the TR 2 / retina. The presence of S-opsin in all TR 2 / photoreceptors indicates that, in the absence of TR 2, all cones follow a default S-cone pathway and suggests a critical role for TR 2 in the commitment of photoreceptors to an M-cone or 'dualcone' phenotype. The effect of TR 2 in cone photodevelopment is not compensated by TR 1 (Ng et al. 2001) .
Thyroid hormones are also critical for development of the auditory system, an observation supported by clinical findings that demonstrate frequent associations between congenital thyroid disorders and hearing impairment or deafness (Refetoff et al. 1967 , Stanbury 1984 , DeLong 1993 . Hypothyroidism has been reported to cause cochlear malformation (Deol 1973 , Uziel et al. 1981 . Recent studies reveal a period extending from late embryonic development to the second postnatal week where T3 is required for normal cochlea development (Deol 1973 , Hebert et al. 1985 , Uziel 1986 ). Exposure to thyroid hormone excess during the same period in rats causes an accelerated onset of auditory function development (Freeman et al. 1993) . The cochlea appears to be the major T3-sensitive auditory organ and TR mRNA is widely distributed in both cochlear and vestibular structures in the developing inner ear (Bradley et al. 1994 ). TR expression is more restricted and predominantly seen in the organ of Corti, which contains primordial hair cells, supporting cells and cells secreting tectorial membrane components. Both TR and TR have been implicated in development of auditory function (Forrest et al. 1996a) , although TR plays the major role. TR / mice exhibit impaired auditory function. Auditory-evoked brainstem response (ABR) studies (Forrest et al. 1996a) have demonstrated that the threshold sound pressure levels required for detection of an ABR were significantly elevated for click stimuli and for all tones tested. Ninety-five percent of TR / mice tested were severely impaired with 10% of these being completely deaf and lacking a response to any stimulus. In mice with some preservation of hearing, the amplitude of ABR waveforms was diminished although their pattern was normal, suggesting that the primary defect in TR / mice lies in the cochlea. The findings indicated that TR controls the maturation of auditory function but is not required for cochlear morphogenesis (Forrest et al. 1996a) . Recent data suggest that the basis for hearing impairment in TR -null mice is a delay in the development of the expression of the fast-activating potassium conductance (IK,f) inner hair cells of the cochlea (Rusch et al. 1998) . In wild-type mice, half-maximal IK,f expression is reached at postnatal day 17·5 whereas, in TR / animals, IK,f expression is absent up to day 18. This difference, at a critical developmental period, may explain the auditory phenotype of TR -null mice (Rusch et al. 1998) . TR 1 and TR 2 isoforms are coexpressed in the developing cochlea, but studies in TR 2 / mice (Abel et al. 1999a) revealed no hearing deficit, indicating that TR 2 is not necessary for cochlear development and function. Rusch et al. (1998) determined ABR thresholds in TR 1 / knockout mice (Wikstrom et al. 1998) . Over a wide range of frequency stimuli, these mice show no impairment, indicating that TR 1 is not essential for auditory function (Rusch et al. 1998) . TR 0/0 mice exhibit a normal hearing threshold at low or middle frequencies, but a marked sensitivity loss at high tone frequencies . In TR 0/0 / mice, the effects on hearing thresholds were significantly more severe than in TR / mice . In summary, TR 1 appears to be the major mediator of T3 action in the ear, although TR is also required for full auditory function.
Small intestine
Thyroid hormones influence postnatal intestinal maturation by stimulating intestinal crypt cell proliferation and the onset of brush border enzyme expression (Castillo et al. 1991 , Hodin et al. 1996 . Thus, T3 enhances the dramatic developmental changes in the gastrointestinal tract that lead to its complete remodelling by adulthood (Tata 1993 , Shi et al. 1996 .
The TR 1 and 2 mRNA isoforms are transcribed from an internal promoter, located in intron 7 of the TR gene (Chassande et al. 1997) . Their expression is highest in a limited number of organs including the lung and small intestine (Fraichard et al. 1997) . TR 1 mRNA is expressed mainly in the epithelium and lamina propria of the distal ileum, with barely detectable levels being seen in the muscular layers of the distal ileum and proximal colon. TR 2 mRNA is similarly distributed, except that maximal expression occurs in the lamina propria of the proximal jejunum . Fraichard et al. (1997) described delayed small intestine development in TR / mice with no overall alterations in stomach, duodenum or colon. The small intestine was smaller, softer and more fragile than in wild-type mice. The diameters of the jejunum and ileum were reduced, together with the number and size of villi, and the total number of epithelial cells per crypt villus unit was reduced by 65% in the ileum. The frequency of goblet cells was reduced 2·5-fold in the ileum of TR / animals, but Paneth cell frequency was unaffected. Circular and smooth muscle layers were reduced, correlating with altered motility in the TR / ileum, which exhibited no spontaneous contraction or response to pharmacological stimuli. Small intestine dipeptidase and disaccharidase activities were reduced 2-fold in TR / mice relative to wild-type mice, although peptide and disaccharide absorption was normal. These are features of delayed intestinal maturation as a similar phenotype is characteristic in young mice.
The small intestine was further characterised by Plateroti et al. (1999) . In TR / mice, the crypt-villus length was shortened in proximal jejunum and distal ileum compared with wild-type mice. These findings correlate with a decreased proliferation rate of TR Freund et al. 1992) . Cdx-1 and Cdx-2 play a key regulatory role in normal intestinal cell proliferation and differentiation (Traber 1994 , Suh & Traber 1996 , Duluc et al. 1997 , Lorentz et al. 1997 ) and reduced expression in TR / mice may account, in part, for the severe small intestine phenotype. Plateroti et al. (1999) observed that a single T3 injection stimulated recovery of intestinal morphology in TR / mice. Furthermore, digestive enzyme activities were partially rescued and Cdx-1 mRNA was restored to normal wild-type levels. Cdx-2 mRNA expression, however, was reduced. In follow-up studies, Plateroti et al. (2001) investigated mechanisms responsible for the intestinal abnormalities in TR / mice. They retain expression of TR 1 and 2, suggesting that expression of these isoforms in the absence of TR 1 may be deleterious to intestinal development. Gauthier et al. (2001) found that, in TR 0/0 animals, the size of the small intestine mucosa was reduced compared with wild-type animals, due to decreased villus length and reduced number of epithelial cells per crypt-villus axis. The features were not as severe as in TR / mice . Furthermore, in TR 0/0 mice, expression of Cdx-1 and Cdx-2 mRNAs remained unchanged relative to wild-type mice, indicating that the TR 1 and 2 mRNAs may exert an inhibitory role to regulate Cdx gene transcription in the absence of TR 1. Thus, the relative level of expression of TR and isoforms in the intestine may be a critical determinant in normal small intestinal development . In order to investigate this, TR 7/7 mutant mice were generated, in which expression of TR 1 and 2 transcripts was almost completely abolished whilst expression of TR 1 and 2 was retained at normal levels. These mice display no morphological alterations in the ileum compared with wild-type mice and, in contrast to both TR / and TR 0/0 mice, TR 7/7 mutants had increased numbers of goblet cells compared with wild-type mice, whilst levels of Cdx-1 and Cdx-2 mRNAs were unchanged . Thus, the severity of the intestinal phenotype correlates with the level of expression of TR transcripts and not with the absence of TR 1 or TR 2 isoforms . Balanced expression of all TR isoforms is essential for normal small intestine development at weaning . TR / mice display no intestinal phenotype, indicating that only TR is essential for postnatal small intestine development . Despite high circulating thyroid hormone levels, there was a marked decrease in the number of epithelial and goblet cells per crypt-villus unit in the distal ileum of TR / / mice, together with severely reduced expression of lactase mRNA and protein and Cdx-1 and Cdx-2 mRNAs ). These data demonstrate that ablation of the TR gene significantly worsens the phenotype observed in TR / mice. Thus, expression of the non-T3-binding TR variants in the absence of all T3-binding TR and isoforms is deleterious to intestinal development, confirming further that a balance between hormone-bound TRs and apo-TR isoforms is essential for intestinal development. Interestingly, distal small intestine epithelial cell proliferation and differentiation are more compromised in Pax8 (Flamant et al. 2002) . These findings provide evidence to support the hypothesis that the TR isoforms play the key role in postnatal small intestinal development (Flamant et al. 2002) .
Liver
TR is the major functional TR in liver, accounting for 80% of hepatic T3-binding activity, with the remainder resulting from TR 1 (Weiss et al. 1998) . Accordingly, TR / mice display altered hepatic T3 responsiveness (Weiss et al. 1998) . Thyroid hormone deprivation causes reduced expression of spot 14 (S14) in wild-type mice, but no change is seen in TR / mice. Similarly, T3 stimulates S14 and malic enzyme (ME) expression in wild-type animals but not in TR / mice. One of the best characterised hepatic T3 target genes is the type I 5 -deiodinase enzyme (D1) which catalyses the conversion of T4 to T3 in liver and kidney (Sato et al. 1984 . D1 is induced by T3 and the human promoter contains several well-studied T3 response elements (Toyoda et al. 1995) . Amma et al. (2001) studied D1 expression in TR-deficient mice and showed, in TR / mice, that liver and kidney D1 mRNA levels were reduced to less than 30% and 50% of wild-type levels respectively. Thus, TR is required for the maintenance of basal D1 expression. The finding that liver D1 mRNA is undetectable in TR 1 / / mice, with enzyme activity less than 0·03% of wild-type mice (Amma et al. 2001) , suggests, however, that TR and TR exert some common functions in liver, although TR appears predominant. In accord with this, TR 1 / mice were found to have a 2-fold elevation in liver D1 expression, presumably resulting from increased TR activity due to elevated T3 concentrations in these animals. Interestingly, renal D1 mRNA expression was not elevated in TR 1 / mice (Wikstrom et al. 1998) , suggesting that the kidney is predominantly a TR -sensitive target organ. Flamant et al. (2002) reported that hepatic D1 expression is significantly reduced in TR Expression of the mutant TR PV which results in RTH was also observed to suppress the magnitude of hepatic T3-target gene responses. Expression of S14, ME and D1 was significantly reduced in TR PV/+ heterozygotes compared with wild-type levels and a further reduction in ME and S14, together with undetectable D1 expression, was evident in TR PV/PV mutants (Kaneshige et al. 2000) . These findings contrast with results obtained in TR -null mice, where no change in ME expression was detected (Weiss et al. 1998 ). In contrast, a different profile of abnormal T3 target gene regulation was reported in TR 1 PV/+ mice. Activity of ME and D1 was increased 2·2-fold and 9·2-fold respectively, indicating hypersensitivity to T3 (Kaneshige et al. 2001) . These findings may result from the markedly increased T3 concentrations in TR 1 PV/+ mice, which may overcome some of the dominant negative activity of the 1 PV mutant receptor and increase T3 responses mediated via TR (Kaneshige et al. 2001) . Hepatic cholesterol metabolism is also influenced by T3, which regulates cholesterol 7 -hydroxylase (CYP7A), the rate-limiting enzyme in bile acid synthesis (Gullberg et al. 2000) . Hypothyroidism is associated with increased serum cholesterol, especially affecting low density lipoprotein (LDL) cholesterol, which can be normalised following T4 replacement (O'Brien et al. 1993) . T3 also influences hepatic synthesis and uptake of cholesterol, controlled largely by hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and LDL receptors (Ness et al. 1973 , Mathe & Chevallier 1976 , Staels et al. 1990 , Ness & Zhao 1994 , and the degradation of cholesterol into bile acids, where the rate-limiting CYP7A is transcriptionally induced by T3 (Mathe & Chevallier 1976 , Crestani et al. 1994 , Pandak et al. 1997 . The normal stimulation of CYP7A mRNA and enzyme activity is unaffected in TR 1 / mice, whereas T3 responsiveness is absent in TR / animals, indicating that TR plays a key role in the regulation of hepatic cholesterol metabolism. Further work, however, has demonstrated an enhanced CYP7A response in T3-deficient TR / mice challenged with dietary cholesterol such that mutant mice did not develop hypercholesterolaemia to the same extent as wild-type controls. The results suggest that TRs influence a range of regulatory effects that may be independent of circulating T3 (Gullberg et al. 2000) .
Heart and thermogenesis
Thyroid hormones influence cardiac conductance, heart rate, cardiac output and cardiac muscle growth. Hypothyroidism leads to bradycardia, whereas hyperthyroidism induces tachycardia. Thyroid hormone plays a crucial role in the control of thermogenesis with hypothyroidism leading to reduced oxygen consumption and heat production. The action of T3 in the heart is mediated predominantly by TR 1 (Gloss et al. 2001) and TR 1 is expressed in the heart at low levels (Falcone et al. 1992) . Wikstrom et al. (1998) reported that TR 1-deficient mice have a lower heart rate than control animals of the same genetic background. However, TR 1 / mice are hypothyroid and when hyperthyroidism is induced the heart rate increases in both TR 1 / and wild-type animals. Nevertheless, the response in TR 1 / mice is suboptimal indicating that ablation of TR 1 reduces intrinsic heart rate and cardiac responsiveness to T3. Thus, TR may influence heart rate via mechanisms that are distinct from the actions of TR 1 or that compensate for it. Electrocardiograph (ECG) recordings revealed a prolonged QRS complex and QT end duration in TR 1 / mice, findings that are similar to those in hypothyroid rat cardiomyocytes (Shimoni & Severson 1995) and hypothyroid patients.
Thyroid hormones control body temperature by stimulating gluconeogenesis and increasing thermogenesis in brown adipose tissue. The 24-hour mean core body temperature was 0·5 C lower in TR 1 / mice, with no significant difference in locomotor activity compared with heterozygotes and wild-type animals. TR 1 / mice also have normal brown adipose tissue mass, suggesting that reduced body temperature results from altered metabolic activity (Wikstrom et al. 1998) . TR / mice, however, have normal body temperature suggesting that the involvement of TR in basal thermogenesis is minor, or may be substituted by TR 1 . There is also a slight increase in heart rate in TR / mice compared with wild-type mice that is not relieved by T3 administration (Weiss et al. 1998 , Johansson et al. 1999 . TR / mice have a reduced QT end time, but exhibit no other ECG abnormalities (Johansson et al. 1999) . HCN2 and HCN4 are cardiac genes that contribute to pacemaker activity by coding for the hyperpolarisation-activated current (Ludwig et al. 1998) . In TR / mice, levels of HCN2 and HCN4 are significantly increased, leading to an increase in contractile function. However, when TR / mice were rendered euthyroid, heart rate and HCN gene expression was normalised (Gloss et al. 2001) , suggesting that T3 responsiveness is mediated via TR . Furthermore, in Pax8 / mice, HCN2 mRNA expression is extremely low, although it is inducible by T3. In compound Pax8 / TR 0/0 mutants, HCN2 expression is restored whereas in Pax8 / TR / animals expression remains low. These results indicate that repression of basal HCN2 expression is mediated via unliganded TR 1 (Flamant et al. 2002) .
Deletion of both TR 1 and TR 2 in TR / mice results in bradycardia and decreased HCN2 and HCN4 gene expression, together with reduced myocardial contractility (Gloss et al. 2001) . TR 0/0 mice, similarly, exhibit a reduced basal heart rate (Macchia et al. 2001) and also have a 0·4 C reduction in body temperature . Reduced cardiac sensitivity to dynamic testing in TR 0/0 mice indicates that TR is the major functional cardiac TR isoform (Macchia et al. 2001) . Furthermore, body temperature data from TR 0/0 mice imply that TR 2 has no effect on thermogenesis under basal conditions . TR 1 / / animals have a similar phenotype to TR / animals, exhibiting basal bradycardia, prolonged PQ and QT end durations, and a 0·4 C reduction in body temperature relative to wild-type mice (Johansson et al. 1998 (Johansson et al. , 1999 . TR 0/0 / mice have a marked mean body temperature reduction of 4 C compared with wild-type mice and reduced HCN2 gene expression (Flamant et al. 2002) . Thus, comparison of temperature reductions in TR / / (0·5 C) and TR 0/0 / (4 C) mice reveals that TR 2 may exert important actions to regulate thermogenesis . Nevertheless, in TR 2 / mice ) a 10% decrease in basal heart rate together with a 0·4 C increase in body temperature was reported. These data are difficult to interpret, however, because of the overexpression of TR 1 in TR 2 / mice that results from the targeting strategy.
In TR 337T transgenic mice, two groups assessed the cardiac phenotype by expressing the transgene either generally (Gloss et al. 1999) or specifically in the myocardium (Pazos-Moura et al. 2000) . The expression of cardiac myosin genes is influenced by T3 (Hoh et al. 1978 , Everett et al. 1984 , Klein & Hong 1986 . In euthyroidism, MHC is the predominant MHC isoform, its expression is increased in thyrotoxicosis, whereas MHC is predominant in hypothyroidism (Izumo et al. 1986 ). In both 337T transgenic models, basal heart rate was reduced. Expression of MHC was increased together with a parallel reduction in MHC expression and ECG studies demonstrated broadening of the QRS complex, indicating prolongation of ventricular depolarisation time. In myocardium-specific 337T mice, the PQ, QR and ST intervals were also prolonged (Pazos-Moura et al. 2000) , which was not the case in mice harbouring the ubiquitously expressed 337T transgene (Gloss et al. 1999) ; although both models displayed a hypothyroid pattern of gene expression, ECG changes and contractile function despite normal T3, T4 and TSH levels.
Central nervous system (CNS) and behaviour
The importance of thyroid hormones in the development of the CNS is well known. TRs are distributed widely throughout the brain, in neurons and glial cells, and the profile of TR expression in different brain regions has been suggested to implicate specific functions for different TR isoforms in CNS development (Forrest et al. 1990 , Bradley et al. 1992 .
In TR / mice, brain size was marginally reduced, but no morphological or cellular differences were observed (Fraichard et al. 1997) . No differences were noted in laminar organisation or brain cytoarchitecture by Nissl staining. Histochemical analysis of acetylcholine esterase and cytochrome oxidase showed no differences in cortical structure or subcortical nuclear organisation between TR / and wild-type mice (Fraichard et al. 1997) . Studies were also performed in TR / mice (Forrest et al. 1996b) . TR / animals completed the Morris water maze test with equal proficiency to wild-type controls. Open field and Y-Maze testing produced similar results. No abnormalities in brain anatomy, including T3-sensitive structures such as the cerebellum and hippocampus, were observed following histological analysis. No overt neurological defects were seen, indicating that the TR gene may have a subtle rather than a major role in CNS development (Forrest et al. 1996b) . TR is induced in neonatal CNS at a critical T3-sensitive period (Forrest et al. 1991 , Mellstrom et al. 1991 and the rise in TR 1 occurs with the onset of the T3-dependent regulation of genes including myelin basic protein (MBP) and Purkinje cell protein-2 (Pcp-2) (Strait et al. 1992) . However, whilst the onset of MBP expression is delayed in the hypothyroid mouse (Farsetti et al. 1992) , no differences in MBP or Pcp-2 mRNA levels were observed in TR / mice compared with wild-type controls, suggesting that TR is not critical for the normal postnatal expression of these T3-dependent genes (Sandhofer et al. 1998) . Taken together, these data suggest that TR and TR mediate redundant actions in the CNS.
To investigate further, TR 1 redundancy between complex compensatory pathways may account for the minimal phenotype. In behavioural tests, TR / animals show no abnormalities and no gross CNS phenotype is observed in TRor TR -deficient animals. However, recent data suggest that the TR 1 and TR genes may have opposite effects on the sexual behaviour of female mice (Dellovade et al. 2000) . Both molecular (Zhu et al. 1996b , Dellovade et al. 1999a and behavioural (Dellovade et al. 1996) studies have shown that thyroid hormones affect the neural systems mediating oestrogen-dependent sexual behaviour in rodents. Dellovade et al. (2000) et al. 2000) . Oxytocin has been reported to facilitate a variety of reproductive and affiliative behaviours (Pedersen et al. 1992) . Thus, oestrogen-influenced oxytocin immunoreactivity in the PVN may explain, in part, the behavioural results of TR 1 / and TR / mice. Although, in many physiological systems, there is co-operation between TRs, this specific behaviour pattern reveals functional antagonism between TR 1 and TR (Dellovade et al. 2000) .
In mice with the RTH TR 337T mutation, marked impairment in balance and co-ordination was observed (Hashimoto et al. 2001 ) following beam and rotorod testing (Scherbel et al. 1999) . In the Morris water maze test (Forrest et al. 1996b) , both heterozygous and homozygous mutants exhibited a learning deficit (Hashimoto et al. 2001) . The defect was similar to that seen in congenital hypothyroidism (Anthony et al. 1993) . TR 337T mice have a smaller cerebellum, although they exhibit no reduction in the size of the forebrain. Haematoxylin and eosin staining of the hippocampus and dentate gyrus revealed no gross morphological differences. However, hippocampal brain-derived neurotrophic factor immunoreactivity was reduced in heterozygous and homozygous mutants. The number of stained granule cells and fibres was especially reduced in the CA3 hippocampal region. TR 337T mice exhibit hypothyroid CNS changes, despite elevated thyroid hormone levels (Hashimoto et al. 2001) , indicating a dominant negative effect of the mutant receptor in vivo. A transgenic mouse with TR 337T selectively targeted to the pituitary has also been developed (Abel et al. 1999b) . These mice show significant down-regulation of prepro-TRH mRNA in the caudal paraventricular hypothalamus. Regional differences in TRH gene expression within the PVN and reduced PVN prepro-TRH mRNA were also observed, suggesting that hypothalamic TRH neurons are extremely sensitive to changes in thyroid status (Abel et al. 1999b) .
Transgenic mice expressing the PV mutant TR exhibit a hyperactivity behavioural phenotype (Wong et al. 1997) . A clinical feature of human RTH is attention deficit hyperactivity disorder, which affects 73% of children and 42% of adults (Brucker-Davis et al. 1995) . The development of structure and function in the mammalian brain is accompanied by marked increases in local rates of glucose utilisation (Duffy et al. 1982 , Kennedy et al. 1982 , which may be sensitive to circulating thyroid hormone levels (Dow-Edwards et al. 1986 ). In targeted knock-in mutant mice, TR PV mRNA has been detected in cerebrum, cerebellum, pituitary gland and systemic organs (Kaneshige et al. 2000) and expression of TR 1 PV mRNA has been identified in both cerebrum and cerebellum (Itoh et al. 2001) . Following determination by the quantitative autoradiographic 2-[ 14 C]deoxyglucose method (Sokoloff et al. 1977) , cerebral glucose utilisation was significantly lower in 4-week-old TR 1 PV/+ mice compared with wild-type mice. TR PV/PV animals, of the same age, showed no change (Itoh et al. 2001) . Expression of Srg1, a member of a protein family involved in the regulation of neurotransmitter release (Fernandez-Chacon et al. 2001) and a T3-positively regulated gene expressed in several brain regions (Thompson 1996) 
Immune system
A role for thyroid hormones in B and T lymphocyte development has been revealed in Snell dwarf mice (Fabris et al. 1971 , Murphy et al. 1992 , MontecinoRodriguez et al. 1996 , 1997 . Arpin et al. (2000) studied TR / mice to determine T3 targets in the immune system and the TRs involved in lymphoid development. They found that the size of the mature B cell pool is altered due to a reduction in progenitor cell proliferation. In TR / mice, no change in primary (thymus and bone marrow) or secondary (spleen) lymphoid organ cell numbers were seen at 10 days of age; however, by postnatal day 24, cell numbers in all lymphoid organs were reduced. The cellularity of T and B cells was reduced by 30% and 60% respectively, and the number of spleen granulocytes and macrophages was also reduced. There was also evidence of haemopoiesis in the TR / spleen (Arpin et al. 2000) . TR / mice suffer from stressinduced defects, which may influence immune function.
Glucocorticoids down-regulate numerous immune processes and induce lymphocyte apoptosis (Wilder 1995 et al. 2000) . Nevertheless, it has been proposed that T3 may act via stimulation of GH-IGF-I secretion from B cells (Weigent et al. 1992 , Geffner 1997 , but this appears unlikely since GH cannot restore the pre-B cell compartment in Snell mice (Montecino-Rodriguez et al. 1996) . Thus, development of the immune system may be influ- (Flamant et al. 2002) , whilst Pax8 / TR 0/0 double mutants showed a recovery of splenic phenotype (Flamant et al. 2002) , suggesting that unliganded TR isoforms, which may include the TR variants, play an important role in spleen development.
Summary
Analysis of the literature indicates that understanding the mechanism of T3 action in vivo has been advanced significantly by the generation of transgenic and knockout mice involving the TR and genes. These mice have provided detailed insight into the roles of the various TR isoforms. However, it is prudent to interpret data obtained from genetically modified mice with caution because of the unavoidable compensatory biological responses that occur following gene deletion or over-expression. Such responses may reveal phenotypes that are indirectly related to TR function or may mask important direct actions of TRs that can be performed by other, normally redundant, pathways. Furthermore, whilst comparisons between genetically modified mice can be very informative, an additional drawback is that different laboratories engineer mutations in mice with different genetic backgrounds.
Such differences may result in significant phenotypic modification. In future studies, therefore, it will be helpful to compare mutations of the TR and genes on uniform genetic backgrounds. In spite of these caveats, genetically modified mice have enabled T3-signalling pathways to be dissected in the intact animal. They have revealed the enormous complexity of TR function and provided a new and deeper understanding of the physiological actions of thyroid hormones.
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